Discovery on Target

In person

Jan Schultz (Managing Director BD) has participated in Discovery on Target, the industry’s preeminent event on novel drug targets and technologies for drug discovery professionals.

The conference highlighted advances in current and emerging “hot” targets and technologies, as well as target validation strategies for the discovery and development of novel therapeutic agents, ranging from biologics to small molecules.